Research · Validation and PoC
Research Edition
Focused on research validation and PoC, proving the continuous biosensor pathway first.
From MakeSense to MatchBioTech.
The team moved from an international biosensor competition to cross-disciplinary prototype validation, clinical insight, and a focused translational direction in continuous L-DOPA monitoring.
Clinical · Clinical continuous monitoring
Clinical Edition
Links concentration feedback, movement data, and visit reports for clinical continuous monitoring scenarios.
Medical · Medicalization and multimodal sensing
Medical Edition
Moves toward medical-device validation and multimodal sensing, preserving an expandable small-molecule monitoring platform.
Cross-disciplinary support network
WiSe Lab, Zhao Lab, iHuman, ShanghaiTech BME, and the School of Life Science support the full-stack iteration from AI-driven biomaterial design to wearable monitoring.
Team development history
- 2024.11 MakeSense team formed
- ShanghaiTech was invited to participate in SensUs 2025
- The first full-stack cross-disciplinary team was formed
- Members came from biology, chemistry, materials, computer science, electronic information engineering, and industrial design
- Three mentors came from biology, biomedical engineering, and design
- 2025.08 Champion in the Netherlands
- Won the SensUs 2025 international championship
- Validated the biosensor verification path
- Beat graduate teams from Cornell, ETH Zurich, TU Delft, and others
- Made MakeSense history and broke the 10-year record
- 2025.08 Commercial exploration
- Conducted a full SensUs commercialization assessment
- Explored commercialization for the creatinine sensor project
- Archived patents, papers, and technical materials
- Started engagement across education, research, industry, and commercialization fields
- 2025.11 Shift to L-DOPA monitoring
- Inspired by SensUs and validated by Parkinson's clinical KOLs
- Started clinical-translation R&D for clinical and frontier detection
- Launched the L-DOPA monitoring pipeline
- 2025.11 Full R&D testing
- Relied on WiSe Lab and Zhao Lab
- Worked with support from iHuman, ShanghaiTech BME, and the School of Life Science
- Advanced full-stack R&D from AI-driven biosensitive-material design to wearable monitoring
- 2026.03 Shanghai MatchBioTech founded
- The team's technical innovation path was validated and in-vitro prototype tests succeeded
- Hospital, patient, and industry research was completed
- Collaboration with the Shanghai Clinical Research Center was established
- The StrivePD China ecosystem outlook was established
- Formal commercialization exploration began
- 2026.05 Product moves toward animal-experiment prep
- Hardware and sensitive materials are advancing together
- The product is about to enter animal experiments
CTA
Talk to us.
We are looking for first-cohort research-edition customers (CROs, pharma, academic labs) and neurology KOLs.